Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The present guidelines represent an evidence-based consensus of the 6th European Joint Task Force involving 10 professional societies.This document has been developed to support healthcare professionals communicating with individuals about their cardiovascular (CV) risk and the benefits of a healthy lifestyle and early modification of their CV risk. In addition, the guidelines provide tools for healthcare professionals to promote population-based strategies and integrate these into national or regional prevention frameworks and to translate these in locally delivered healthcare services, in line with the recommendations of the World Health Organization (WHO) global status report on non-communicable diseases 2010.
1.1 Definition and rationale
1.2 Development of the 6th Joint Task Force guidelines
1.3 Cost-effectiveness of prevention
2.1 Estimation of total cardiovascular risk
2.2 When to assess total cardiovascular risk?
2.3 How to estimate total cardiovascular risk?
2.4 Other risk markers
2.5 Relevant groups
3a. How to intervene at the individual level: risk factor intervention
3a.1 Behaviour change
3a.2 Psychosocial factors
3a.3 Sedentary behaviour and physical activity
3a.4 Smoking intervention
3a.6 Body weight
3a.7 Lipid control
3a.8 Diabetes mellitus (type 2 and type 1)
3a.10 Antiplatelet therapy
3a.11 Adherence to medication
3b. How to intervene at the individual level: disease specific intervention Atrial fibrillation, coronary artery disease, chronic heart failure, cerebrovascular disease, peripheral artery disease (web addenda)
3c. How to intervene at the population level
3c.1 Introduction (healthy lifestyle promotion)
3c.2 Population-based approaches to diet
3c.3 Population-based approaches to physical activity
3c.4 Population-based approaches to smoking and other tobacco use
3c.5 Alcohol abuse protection
3c.6 Healthy environment
4a. Where to intervene at the individual level
4a.1 Clinical settings and stakeholders
4a.2 How to monitor preventive activities
4b. Where to intervene at the population level
4b.1 Government and public health
4b.2 Non-governmental organizations
© 2017 European Society of Cardiology. All rights reserved